- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Services
- Sub-Industry: Medical Labs&Testing Srv
Snapshot for Miraca Holdings Inc (4544)
| Open: | 4,920 | Day's Range: | 4,820 - 4,930 | Volume: | 96,900 |
|---|---|---|---|---|---|
| Previous Close: | 4,915 | 52wk Range: | 2,920 - 5,180 | 1-Yr Rtn: | +64.45% |
Key Statistics for 4544
| Current P/E Ratio (ttm) | 19.0632 |
|---|---|
| Estimated P/E(03/2014) | 18.6757 |
| Relative P/E vs. TPX | 0.7727 |
| Earnings Per Share (JPY) (ttm) | 254.9420 |
| Est. EPS (JPY) (03/2014) | 260.2310 |
| Est. PEG Ratio | 1.6240 |
| Market Cap (M JPY) | 285,345.00 |
| Shares Outstanding (M) | 58.71 |
| 30 Day Average Volume | 256,810 |
| Price/Book (mrq) | 2.0686 |
| Price/Sale (ttm) | 1.4750 |
| Dividend Indicated Gross Yield | 1.77% |
| Cash Dividend (JPY) | 43.0000 |
| Last Dividend | 09/26/2013 |
| 5 Year Dividend Growth | 12.70% |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4544
Company Profile & Key Executives for 4544
Miraca Holdings Inc. develops, manufactures, exports, and imports clinical reagents, medical drugs, and medical equipment. The Company's clinical reagents are for cancer, malignant tumor, hypothyroidism, diabetes, and infectious diseases including AIDS. Miraca Holdings also conducts clinical tests for hospitals and medical organizations.
| Hiromasa SuzukiPresident | Shinji OgawaSenior Executive Officer |
| Hiromitsu TazawaSenior Executive Officer | Takeshi KoyamaExecutive Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4544 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page